Item 9A. Controls and Procedures
ITEM
9A. CONTROLS AND PROCEDURES
Disclosure
Controls and Procedures
Our
Company conducted an evaluation, under the supervision and with the participation of the Company’s management, including the Company’s
principal executive officer and principal financial officer, of the effectiveness of the design and operation of its disclosure controls
and procedures as defined in Rules 13a-15(e) and 15-d-15(e) under the Securities Exchange Act of 1934, as amended (the “Exchange
Act”) as of the end of the period covered by this Form 10-Q. Based on that evaluation, our Company’s principal executive
officer and principal financial officer have concluded that our disclosure controls and procedures were not effective.
Management’s
Annual Report on Internal Control over Financial Reporting
This
annual report does not include a report of management’s assessment regarding internal control over financial reporting or an attestation
report of the company’s registered public accounting firm due to a transition period established by rules of the Securities and
Exchange Commission for newly public companies.
Changes
in Internal Controls over Financial Reporting
There
have been no changes in our internal control over financial reporting (as defined in Rules 13a-15(f) and 15d-15(f) under the Exchange
Act) during the period covered by this Form 10-K that have materially affected or are reasonably likely to materially affect, our internal
control over financial reporting.
ITEM
9B. OTHER INFORMATION
Not applicable
ITEM
9C. DISCLOSURE REGARDING FOREIGN JURISDICTIONS THAT PREVENT INSPECTIONS
Not applicable
ITEM
10. DIRECTORS, EXECUTIVE OFFICERS AND CORPORATE GOVERNANCE
Directors,
executive officers, promoters and control persons
Name
Age
Positions(s)
Deven
Soni
45
Chairman,
President and Chief Executive Officer
Christopher
Creatura
35
Chief
Financial Officer
David
Hackett
61
Director
Jaime
Leverton
48
Director
(1) Directors currently have an indefinite term of
office and have served in that capacity since July of 2024.
Family Relationships
Not applicable
Business
Experience
Deven
Soni is our Chairman, President, Chief Executive Officer and Director and has served in that capacity since May 3, 2024. Mr.
Soni, age 45, combines over 20 years of experience in senior management within the investment and technology industries, following a
2-year career as an investment banker at Lazard (2002–2004). From 2006 to 2008, he was an Investment Professional at Goldman Sachs,
focusing on technology buyouts and venture capital, and from 2008 to 2010, he held a similar role at Highland Capital Partners. Mr. Soni
co-founded Wired Investors (2016–2022), a tech-focused buyout firm, and Acquira (2018–2022), a business acquisition vehicle.
He served as Founding COO at Tokens.com (2021–2023), a blockchain infrastructure company, and co-founded Snowball Industries in
2020, an HVAC roll-up. Currently, Mr. Soni is Chairman of the Board at Matador Gold Technologies (2022–Present) and serves on the
boards of Snowball Industries (2020–Present), and Polymath Research Inc. (2017–Present). He holds a Bachelor of Science degree
in Business Administration from the University of California, Berkeley (1998–2001).
Christopher
Creatura is our Chief Financial Officer and has served in that capacity since May 3, 2024. Mr. Creatura, age 35, is a finance
professional and investor. He began his career as a consultant at Deloitte. He moved into investment banking at BofA Merrill Lynch and
then private equity at Enduring Ventures. He has since held executive roles at Bluefin Trading (VP of Growth) and Live Patrol (CFO &
CSO). He has also advised on M&A transactions and capital raises through his firm Conway Merchants. Mr. Creatura serves on the board
of The Fitting Room. He is a CPA.
16
David
Hackett serves on our Board of Directors and has served in that capacity since July 1, 2024. David Hackett, Director, age 61,
combines over 20 years of experience in senior management as a Director and/or Chief Financial Officer. He was previously the CFO of
48North Cannabis Corp., a licensed cannabis producer (TSXV:NRTH); Mavencare Inc., providing personalized home care services to keep seniors
safe and independent at home; Coupgon Inc, Canada’s first fully digital grocery coupon solution (sold to a joint venture between
Yellow Pages and CGI), and Diversinet Corp., a Nasdaq and TSXV listed company, specializing in the infrastructure that wireless software
applications need for secure, confidential and authenticated data exchanges. He is also currently a director of Ayurcann Holdings Corp.,
a licensed producer under the Cannabis Act (Canada); Polymath Research Inc., a software development company and Belmont House Foundation,
a long-term care facility. Mr. Hackett is a CA, CPA and holds an MBA from the Ivey Business School at the Western University.
Jaime
Leverton serves on our Board of Directors and has served in that capacity since July 1, 2024. Jaime Leverton, Director, age 48, combines
over 24 years of experience in senior management within the technology and digital infrastructure industries. She has held leadership
roles at prominent companies, including IBM (2000–2009), Bell Canada (2010–2014), BlackBerry (2014–2016), National
Bank of Canada (2016–2017), Cogeco Peer 1 (2017–2019), and eStruxture Data Centers (2019–2020). Most recently, she
served as CEO of Nasdaq-listed Hut 8 Mining Corp. (2020–2024), where she led strategic transformation and growth. Ms. Leverton
is currently the CEO of Ulys Holdings (2024–Present) and Chairperson of Synteq Digital (2024–Present). She holds a Bachelor
of Social Science from the University of Ottawa, an MBA from Dalhousie University, and an ICD.D designation from the Rotman School of
Management.
Involvement
in Certain Legal Proceedings
Not
applicable
Promoters
and Control Persons
Not
applicable
Code
of Ethics
On
September 12, 2024 the Board of Directors adopted a Code of Ethics and Business Conduct which is applicable to our future employees,
and which also includes a Code of Ethics for our chief executive and principal financial officers and any persons performing similar
functions. A code of ethics is a written standard designed to deter wrongdoing and to promote:
●
honest
and ethical conduct,
●
full,
fair, accurate, timely and understandable disclosure in regulatory filings and public statements,
●
compliance
with applicable laws, rules and regulations,
●
the
prompt reporting violation of the code, and
●
accountability
for adherence to the code.
Please
refer to exhibit 14.1 attached to this filing for additional information regarding our code of ethics.
17
Nominating
Committee-Material Changes to Procedures
The
Company does not currently have procedures by which security holders may recommend nominees to our board of directors.
Audit
Committee
As
the Company is not considered a listed issuer (as defined in Rule 10A-3 of the Exchange Act) the information in Item 407(d)(4)(ii) of
Regulation S-K has not been provided. Further, as i) the Company is a smaller reporting company and ii) this is our first annual report
following the effective date of our first registration statement filed under the Securities Act, the Company has not provided the information
in Item 407(d)(5) of Regulation S-K.
Insider
Trading Arrangements and Policies
The
Company has adopted insider trading policies and procedures governing the purchase, sale, and/or other dispositions of our securities
by directors, officers and employees, or the Company itself, that are reasonably designed to promote compliance with insider trading
laws, rules and regulations. The Company is not subject to any listing standards at this time. A copy of the Company’s insider
trading policy has been attached to this filing in exhibit 19.1.
ITEM
11. EXECUTIVE COMPENSATION
Summary
Compensation Table
The
following table summarizes all compensation for the two years ended September 30, 2025 earned by our “Executive Officers”.
Name and principal position
Year¹
Salary ($)
Stock Awards ($)
Option Awards ($)²
Nonequity incentive plan compensation ($)
Nonqualified deferred compensation earnings ($)
All Other Compensation ($)
Total ($)
Devon Soni-Chairman, President and Chief Executive Officer
2025
$ 164,000
58,200
30,000
$ 252,200
2024
$ 60,000
-
1,177,500
-
-
-
$ 1,237,500
Christopher Creatura-Chief Financial Officer³
2025
$ 165,000
68,713
$ 233,713
2024
$ 60,000
-
363,750
-
-
-
$ 423,750
Chris Johnson-Chief Sales Officer
2025
$ 75,000
-
$ 75,000
2024
-
-
242,500
-
-
-
$ 242,500
(1)
The Company was formed on May 3, 2024
(2)
For information regarding the assumptions made in determining the fair value of the granted options please refer to the footnotes to
the Company’s consolidated financial statements included in the filing
(3)
Chris Johson, former Chief Sales Officer, was separated from the Company during August of 2025. As a result of the separation options
that were granted during the year were subsequently cancelled.
(4)
For Christopher Creatura, $60,000 of his 2025 salary was accrued for as of September 30, 2025
Narrative
Disclosure to Summary Compensation Table
On
July 1, 2024, we entered into an employment agreement with Mr. Deven Soni for his services as our Chief Executive Officer and President.
The agreement is for a period of 5 years and renews automatically thereafter for subsequent one-year terms. Pursuant to the agreement,
Mr. Soni received a base salary of $120,000 from July 1, 2024, to December 31, 2024. Effective January 1, 2025, the Base Salary increased
to $180,000 per year. He has an opportunity to receive performance-based compensation in the amount of 50% of his base salary, and in
no event less than $40,000, based upon the achievement of annual performance goals established by the Board/Compensation
18
Committee
of the Board (the “Compensation Committee”). In addition, Mr. Soni was also granted 1,500,000 options during July of 2024.
The options vest ratably over a three-year period (with 1/3 rd vesting at each anniversary of the grant date) and do not contain
any provision that could cause the exercise price to be lowered. In January 2025, the Company granted Mr. Soni an additional 120,000
stock options as his performance bonus for fiscal year 2024. The options vested immediately upon grant. He is also eligible to participate
in any long-term incentive compensation programs that become available to our executive officers. Mr. Soni has 14 days of paid vacation
per calendar year (prorated for partial years) in accordance with the Company’s vacation policies, as in effect from time to time.
To the extent permitted under applicable law, Mr. Soni’s vacation time that accrues during any given year may not roll over to
a subsequent year. Mr. Soni is further entitled to participate in other benefit plans made available to our employees and executive officers
from time to time.
On
July 1, 2024, we entered into a consultant agreement with Mr. Creatura for his services as our Chief Financial Officer. Pursuant to the
agreement, Mr. Creatura received a base fee of $120,000 from July 1, 2024, to December 31, 2024. Effective January 1, 2025, the base
fee increased to $180,000 per year.. He has an opportunity to receive performance-based compensation in the amount of 50% of his base
fee, and in no event less than $40,000, based upon the achievement of annual performance goals established by the Board/Compensation
Committee of the Board (the “Compensation Committee”). In addition, Mr. Creatura was also granted 750,000 options during
July of 2024. The options vest ratably over a three-year period (with 1/3 rd vesting at each anniversary of the grant date)
and do not contain any provision that could cause the exercise price to be lowered. In January 2025, the Company granted Mr. Soni an
additional 120,000 stock options as his performance bonus for fiscal year 2024. The options vested immediately upon grant. In addition,
during January 2025, the Company granted Mr. Creatura 21,677 stock options in recognition of services rendered during fiscal year 2024.
These options also vested immediately upon grant. He is also eligible to participate in any long-term incentive compensation programs
that become available to our executive officers.
On
July 1, 2024 we entered into a consultant agreement with Mr. Christopher Johnson for his services as Chief Sales Officer. Pursuant to
the agreement, Mr. Johnson received a base fee of $180,000 beginning January 1, 2025. Additionally, he received a commission on sales
he originated. He had an opportunity to receive performance-based compensation in cash or shares based on gross profit targets. During
the period ended September 30, 2025, Mr. Johnson received a $78,080 commission for sales of equipment to customers. In addition, Mr.
Johnson was also granted 500,000 options during July of 2024. The options vested ratably over a three-year period (with 1/3 rd vesting
at each anniversary of the grant date) and did not contain any provision that could cause the exercise price to be lowered. In January
2025, the Company granted Mr. Johnson 2,000,000 stock options. The options vested ratably over a three-year period (with 1/3 rd vesting
at each anniversary of the grant date). He was also eligible to participate in any long-term incentive compensation programs that become
available to our executive officers. Mr. Johnson’s consulting agreement with the Company terminated in August 2025. As a result
of his separation from service, all unvested stock options were automatically cancelled in accordance with the terms of his option agreement,
and Mr. Johnson did not retain any rights to the unvested portion of the award.
Outstanding
Equity Awards at Fiscal Year-End Table
Option awards
Stock awards
Name
Number of
securities underlying
unexercised options
exercisable
(#)
Number of
securities underlying
unexercised options
unexercisable
(#)
Equity incentive
plan awards:
Number of securities
underlying unexercised
unearned options
(#)
Option
exercise
price
($)
Option
exerpiration
date
Number of
shares or units
of stock that
have not vested (#)
Market Value of
shares or units
of stock that
have not vested ($)
Equity incentive
plan awards:
Number of unearned
shares, units or
other rights that
have not vested
(#)
Equity incentive
plan awards:
Market or payout value
of unearned shares,
units or other rights
that have not vested
($)
Devon Soni
703,333
-
916,667
$ 0.05
July 1, 2034 through January 1, 2035
-
-
-
-
Chris Creatura
433,434
-
458,243
$ 0.05
July 1, 2034
-
-
-
-
Director
Compensation
The
Company’s directors did not receive any compensation during our fiscal year ended September 30, 2025.
Disclosure
of the registrant’s policies and practices related to the grant of certain equity awards close in time to the release of material
nonpublic information.
Not
applicable
19
Compensation
Committee Interlocks and Insider Participation and Compensation Committee Report
As
a smaller reporting company we are not required to provide the information in Item 407(e)(4)-(5) of Regulation S-K.
ITEM
12. SECURITY OWNERSHIP OF CERTAIN BENEFICIAL OWNERS AND MANAGEMENT AND RELATED STOCKHOLDER MATTERS
Title of class ¹
Name and address of benefical owner
Amount and nature
of benefical ownership
Percent of Class ²
Common Stock
AASD Capital LLC (Devon Soni)
1887 Whitney Mesa Dr. #9810
Henderson, NV 89014, USA²
2,571,000
27 %
Common Stock
TDK Cashflow Ltd. (Trevor Koverko)
180 University Ave, Suite 6202
ON, M5H OA2, Canada
1,900,000
20 %
Common Stock
Tiger Trout Capital Puerto Rico LLC (Allan Masley)
1357 Ashford Ave. Ste 2-267
San Juan, PR USA 907
830,000
9 %
(1)
Based on the Company’s shareholder report as of the date of the filing which reflected 9,440,362 common shares outstanding.
(2)
Amount includes 786,000 shares with respect to which such listed beneficial owner has the right to acquire beneficial ownership as specified
in Rule 13d-3(d)(1) under the Exchange Act.
SECURITY
OWNERSHIP OF MANAGEMENT
Title of class
Name of benefical owner
Amount and nature
of benefical ownership
Percent of Class
Common Stock
Devon Soni¹
2,571,000
27 %
Common Stock
Christopher Creatura
272,000
3 %
Common Stock
David Hackett
170,000
2 %
Common Stock
Jaime Leverton
72,052
1 %
Common Stock
Directors and Exectuive Officers as a group
3,085,052
33 %
(1)
Amount includes 786,000 shares with respect to which the person has the right to acquire beneficial ownership as specified in Rule 13d-3(d)(1)
under the Exchange Act.
ITEM
13. CERTAIN RELATIONSHIPS AND RELATED PARTY TRANSACTIONS
Transactions
with Related Persons, Promoters and Certain Control Persons
The
Company did not enter into any related party transactions during the two years ended September 30, 2025.
Director
Independence
Our
board consists of three directors, two of which are considered independent. While the Company has an audit committee, we do not have
compensation or nominating committee. Further, while the Company is not a listed issuer, it uses the definition of independence as outlined
in NASDAQ’s Corporate Governance Requirements section.
ITEM
14. PRINCIPAL ACCOUNTANT FEES AND SERVICES
For the fiscal year ended September 30,
2025
2024
Audit Fees
$ 76,000
$ 30,000
Audit Related Fees
-
-
Tax Fees
-
-
Other Related Fees
-
-
PART
IV
ITEM
15. EXHIBITS AND FINANCIAL STATEMENT SCHEDULES
20
SIGNATURES
Pursuant
to the requirements of the Securities Act of 1933, the registrant has duly caused this registration statement to be signed on its behalf
by the undersigned, thereunto duly authorized.
VERTICAL
DATA INC.
/s/
Deven Soni
Deven
Soni
Chairman,
President, Chief Executive Officer
December
29, 2025
Pursuant
to the requirements of the Securities Act of 1933, this registration statement has been signed by the following persons in the capacities
and on the dates indicated.
/s/
Christopher Creatura
Christopher
Creatura
Chief
Financial Officer
December
29, 2025
21
EXHIBIT
INDEX
Exhibit
Number
Name/Identification
of Exhibit
3.1+
Articles of Incorporation
3.2+
Bylaws
10.1+
Form of Vertical Data, Inc’s 2024 Equity and Incentive Plan
14.1+
Code of Ethics
19.1*
Insider Trading Policies and Procedures
31.1+
Rule 13a-14/15d-14 Certification of the CEO
31.2+
Rule 13a-14/15d-14 Certification of the CFO
32.1+
Section 1350 Certifications of the CEO
32.2+
Section 1350 Certification of the CFO
101. INS
Inline XBRL Instance Document*
101.SCH
Inline XBRL Taxonomy Extension
Schema Document*
101.CAL
Inline XBRL Taxonomy Extension
Calculation Linkbase Document*
101.DEF
Inline XBRL Taxonomy Extension
Definition Linkbase Document*
101.LAB
Inline XBRL Taxonomy Extension
Label Linkbase Document*
101.PRE
Inline XBRL Taxonomy Extension
Presentation Linkbase Document*
104
Cover Page Interactive
Data File (Embedded as Inline XBRL document and contained in Exhibit 101)*
+
previously filed
*
Filed herewith
22
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.